Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01665352 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
A Phase 2 study of Type 2 Diabetes Mellitus, sponsored by vTv Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 186
- Enrollment target
- 19
- Study locations
NCT01665352 is a Phase 2 study of Type 2 Diabetes Mellitus that has completed, run by vTv Therapeutics. The registered enrollment target is 186 participants, below the 2,747-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (93% lower). The trial reports 19 study locations across 14 states.
The verdict
NCT01665352, a Phase 2 study of Type 2 Diabetes Mellitus, has completed, sponsored by vTv Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 186 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of this study is to compare the safety and effect of TTP054 versus placebo on glucose control in patients with type 2 diabetes.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG TTP054
Study Locations (19)
Texas
- Site 16 - Dallas
- Site 10 - Houston
- Site 2 - Houston
- Site 11 - Katy
California
- Site 18 - Chula Vista
- Site 1 - Los Angeles
Florida
- Site 4 - Coral Gables
- Site 5 - Port Orange
Colorado
- Site 13 - Denver
Hawaii
- Site 3 - Honolulu
Indiana
- Site 17 - Indianapolis
Kentucky
- Site 7 - Louisville
Maine
- Site 8 - Auburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01665352
The ClinicalTrials.gov registry entry for NCT01665352 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,747-participant average among 122 other Type 2 Diabetes Mellitus trials with a reported enrollment target (93% lower). The listed sponsor is vTv Therapeutics, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01665352 reports 19 study locations spanning 14 distinct geographic areas - top geographies include Texas, California, Florida.
Frequently Asked Questions
What is clinical trial NCT01665352 about?
NCT01665352 is a clinical study titled "A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes". The purpose of this study is to compare the safety and effect of TTP054 versus placebo on glucose control in patients with type 2 diabetes.
What is the current status of trial NCT01665352?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 186 participants. The study started on 2012-08. Estimated completion is 2013-05.
What conditions does trial NCT01665352 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus.
What interventions are being tested in trial NCT01665352?
The interventions under investigation include: Placebo (DRUG), TTP054 (DRUG).
Who is sponsoring clinical trial NCT01665352?
This trial is sponsored by vTv Therapeutics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01665352 being conducted?
This trial has 19 study locations across California, Colorado, Florida, Hawaii, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
RECRUITING · Phase 2
-
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
RECRUITING · Phase 2
-
Regulation of Endogenous Glucose Production by Central KATP Channels
RECRUITING · Phase 2
-
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
COMPLETED · Phase 2
-
The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes
COMPLETED · Phase 2
-
Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.